In addition, we selected three HNSCC-biopsy-derived cell lines with high CDDP resistance (>10 μM) as described [23] to test the effect of SDCBP inhibition on the CDDP response (Figure 1E). The gene discussed is SDCBP; the disease is head and neck squamous cell carcinoma.